Safety classification systems used in dermatological medication risk counseling of pregnant and lactating patients: A case for an evidence-based approach

Dermatologic Therapy

Volumn 26, Issue 4, 2013, Pages 347-353

  Millsop, Jillian Wong ^a   Heller, Misha M ^b   Murase, Jenny E ^c,d  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d PALO ALTO MEDICAL FOUNDATION   (United States)

Author keywords

Evidence based medicine; Lactation; Pregnancy; Risk classification

Indexed keywords

ADALIMUMAB; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; BCG VACCINE; CLOTRIMAZOLE; CORTICOSTEROID; DERMATOLOGICAL AGENT; DIPHENHYDRAMINE; EFALIZUMAB; ETANERCEPT; FLUCONAZOLE; HYDROCORTISONE; HYDROXYZINE; INFLIXIMAB; KETOCONAZOLE; LIVE VACCINE; NON PRESCRIPTION DRUG; NYSTATIN; STEROID;

ABSENCE OF SIDE EFFECTS; ANTLEY BIXLER SYNDROME; ANUS ATRESIA; ARACHNODACTYLY; ARTICLE; BONE BOWING; CAMPTODACTYLY; CANDIDIASIS; CHOANA ATRESIA; CLEFT LIP; CLEFT PALATE; CLUBFOOT; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CRANIOFACIAL MALFORMATION; CRANIOFACIAL SYNOSTOSIS; CROHN DISEASE; DERMATITIS; DIARRHEA; DRUG CLASSIFICATION; DRUG MEGADOSE; DRUG SAFETY; DRUG USE; EAR DYSPLASIA; EVIDENCE BASED MEDICINE; EVIDENCE BASED PRACTICE; EXOPHTHALMOS; FEEDING DISORDER; FETUS HYPOXIA; FIRST TRIMESTER PREGNANCY; FOOD AND DRUG ADMINISTRATION; GROWTH DISORDER; HUMAN; JOINT CONTRACTURE; KIDNEY MALFORMATION; LACTATION; LOW BIRTH WEIGHT; NONHUMAN; NOSE MALFORMATION; PATIENT COUNSELING; PERINATAL PERIOD; PREGNANCY; PREGNANT WOMAN; PREMATURE LABOR; PRURITUS; PSORIASIS; RETROLENTAL FIBROPLASIA; RISK ASSESSMENT; SKELETON MALFORMATION; SKIN ALLERGY; SKIN CANDIDIASIS; SYNOSTOSIS; TERATOGENICITY; THIRD TRIMESTER PREGNANCY; TRACHEOESOPHAGEAL FISTULA; TREMOR; UTERUS CONTRACTION; VERTEBRA MALFORMATION; WITHDRAWAL SYNDROME;

EVIDENCE-BASED MEDICINE; LACTATION; PREGNANCY; RISK CLASSIFICATION;

COUNSELING; DERMATOLOGIC AGENTS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LACTATION; PREGNANCY; PREGNANCY COMPLICATIONS; RISK;

EID: 84885232816     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12015     Document Type: Article

References (28)

1. Rubin JD, Ferencz C, Loffredo C. Use of prescription and non-prescription drugs in pregnancy. The Baltimore- Washington Infant Study Group. J Clin Epidemiol 1993: 46: 581-589.
2. Charlton RA, Cunnington MC, de Vries CS, Weil JG. Data resources for investigating drug exposure during pregnancy and associated outcomes: the General Practice Research Database (GPRD) as an alternative to pregnancy registries. Drug Saf 2008: 31: 39-51.
3. Boothby LA, Doering PL. FDA labeling system for drugs in pregnancy. Ann Pharmacother 2001: 35: 1485-1489.
4. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998: 30: 24-29, 46.
5. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998: 338: 1128-1137.
6. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 4th ed. Baltimore, MD: Williams &Wilkins, 1994.
7. Washington Uo. FDA Pregnancy Categories1997-2000, 2012.
8. FASS. Classification of medical products for use during pregnancy and lactation. The Swedish system. Stockholm: LINFO, Drug Information Ltd, 1993.
9. Committee ADE. Medicines in Pregnancy. An Australian Categorization of Risk. An Australian Categorization of Risk, 1992.
10. Addis A, Sharabi S, Bonati M. Risk classification systems for drug use during pregnancy: are they a reliable source of information? Drug Saf 2000: 23: 245-253.
11. Sannerstedt R, Lundborg P, Danielsson BR, et al. Drugs during pregnancy: an issue of risk classification and information to prescribers. Drug Saf 1996: 14: 69-77.
12. Schaefer C, Miller RK. Drugs during pregnancy and lactation: treatment options and risk assessment: treatment options and risk assessment, 2nd ed. Amsterdam: Elsevier Academic Press, 2007.
13. Zierler S, Purohit D. Prenatal antihistamine exposure and retrolental fibroplasia. Am J Epidemiol 1986: 123: 192-196.
14. Lione A, Scialli AR. The developmental toxicity of the H1 histamine antagonists. Reprod Toxicol 1996: 10: 247-255.
15. Brost BC, Scardo JA, Newman RB. Diphenhydramine overdose during pregnancy: lessons from the past. Am J Obstet Gynecol 1996: 175: 1376-1377.
16. Lopez-Rangel E, Van Allen MI. Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype. Birth Defects Res A Clin Mol Teratol 2005: 73: 919-923.
17. Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J. Case Report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohns Colitis 2010: 4: 603-605.
18. Heller MM, Wu JJ, Murase JE. Fatal case of disseminated BCG infection after vaccination of an infant with in utero exposure to infliximab. J Am Acad Dermatol 2011: 65: 870.
19. Carter JD, Valeriano J, Vasey FB. Tumor necrosis factoralpha inhibition and VATER association: a causal relationship. J Rheumatol 2006: 33: 1014-1017.
20. Chi CC, Lee CW, Wojnarowska F, Kirtschig G. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev 2009: (3): CD007346.
21. Alabdulrazzaq F, Koren G. Topical corticosteroid use during pregnancy. Can Fam Physician 2012: 58: 643-644.
22. Chi CC, Kirtschig G, Aberer W, et al. Evidence-based (S3) guideline on topical corticosteroids in pregnancy. Br J Dermatol 2011: 165: 943-952.
23. Health TUSDoHaHSOoWs. HHS Blueprint for Action on Breastfeeding U.S. Department of Health and Human Services, 2000.
24. General TUSDoHaHSOotS. The Surgeon General's Call to Action to Support Breastfeeding. Washington D.C.: U.S. Department of Health and Human Services, 2011.
25. Nordeng H, Havnen GC, Spigset O. Drug use and breastfeeding. Tidsskr Nor Laegeforen 2012: 132: 1089-1093.
26. Drugs AAoPCo. Transfer of drugs and other chemicals into human milk. Pediatrics 2001: 108: 776-789.
27. Feldman-Winter LB, Schanler RJ, O'Connor KG, Lawrence RA. Pediatricians and the promotion and support of breastfeeding. Arch Pediatr Adolesc Med 2008: 162: 1142-1149.
28. Hale TW.Medications and mothers' milk, 14th ed. Amarillo, TX: Hale Pub, 2010.